Loading...
XSHE
300110
Market cap590mUSD
Dec 05, Last price  
3.53CNY
1D
-0.84%
1Q
4.75%
Jan 2017
-60.65%
IPO
-18.48%
Name

Huaren Pharmaceutical Co Ltd

Chart & Performance

D1W1MN
XSHE:300110 chart
P/E
P/S
3.08
EPS
Div Yield, %
0.59%
Shrs. gr., 5y
Rev. gr., 5y
-1.53%
Revenues
1.35b
-17.30%
161,141,445207,572,968288,546,637338,303,704405,311,965562,034,145867,200,339916,761,3521,105,896,0421,248,972,1981,311,875,3651,383,859,3371,461,940,6241,316,592,2381,560,855,3941,619,492,3351,636,256,3561,353,161,818
Net income
-1.37b
L
34,140,64646,430,66160,766,35276,319,46487,560,91796,587,698121,519,38656,153,98522,936,49823,946,24437,535,03538,794,83742,066,21394,623,997130,404,876180,779,025188,063,014-1,368,478,968
CFO
322m
+5.49%
7,659,89957,244,29838,627,59777,608,75259,530,88599,442,78339,779,06065,562,08518,766,954181,650,110211,080,360254,316,028309,331,52400217,984,061305,597,473322,359,889
Dividend
Jul 10, 20240.021 CNY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Huaren Pharmaceutical Co., Ltd. produces and sells non-PVC soft bag infusions in China. The company offers doxofylline, levofloxacin hydrochloride, compound potassium hydrogen phosphate, and caffeine citrate, sodium chloride, glucose, glucose sodium potassium chloride, compound sodium chloride, sodium lactate ringer, compound electrolyte, and sterilized water injections. It also provides therapeutic infusion products for blood volume expansion, hemostasis, nervous and circulatory systems, anti-infection, anti-hepatitis, hepatitis adjuvant, anti-tumor, and carbohydrate metabolism; and medical instruments, such as disposable incision retractors, disposable cannula puncture devices disposable specimen extractors, abdominal suction tubes, incision retractor protectors, iodine solution protective caps, slip pads, respiratory oscillation expectoration machines, protective mask cup types, protective and foldable disposable masks, and medical protective masks. In addition, the company offers pharmaceutical packaging materials, including rubber stopper, carton, and membrane; rinsing fluid and API series products; and food and beverage, and medical skin care products. Huaren Pharmaceutical Co., Ltd. was founded in 1998 and is based in Qingdao, China.
IPO date
Aug 25, 2010
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT